CervoMed (CRVO) Announces Up to $149.4M Private Placement Financing
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 9/11/2026
- S&P 500 ends higher as strong inflation data cements rate-hike bets
- Oracle raises full year profit guidance, stock rises after hours
- Oil falls but head for 8% weekly gain on tight supply; US diesel hits record
- 'No panic anywhere' may be the problem, BofA strategists warn
- Buy Shopify stock at this ’AI-enabled entry point,’ analyst says
- After-Hours Movers: ORCL, CRWV, ADBE, ACVA, CPRT, ZUMZ, PMTS, RH
- After-Hours Movers: COO, AEO, NAVN, AVAV, TORO
- After-Hours Movers: LULU, IOT, PATH, DOCU, ASAN, GWRE, ZS, PL, SWBI, OXM
- After-Hours Movers: AVGO, SNOW, HPE, NTAP, NTSK, CHPT, FIVE, TLYS, PVH, RARE
- After-Hours Movers: DELL, PANW, GTLB, CRDO, MDB, HPE, SMCI
CervoMed Announces Up to $149.4 Million Private Placement Financing Joined by Leading Healthcare Investors
March 28, 2024 8:30 AM EDTFunding from new investors, including RA Capital Management, Armistice Capital, Special Situations Funds and Soleus Capital
$50 million financing upfront with up to an additional $99.4 million tied to exercise of warrants
Pro forma cash and cash equivalents from upfront proceeds expected to provide runway through the end of 2025
BOSTON, March 28, 2024 (GLOBE NEWSWIRE) -- CervoMed Inc. (NASDAQ: CRVO), a clinical-stage company focused on developing treatments for age-related neurologic disorders (the Company), today announced that it has entered into a definitive securities purchase agreement for a private... More
